JM Lambert

1.0k total citations
19 papers, 851 citations indexed

About

JM Lambert is a scholar working on Immunology, Neurology and Molecular Biology. According to data from OpenAlex, JM Lambert has authored 19 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 8 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in JM Lambert's work include Toxin Mechanisms and Immunotoxins (16 papers), Neuroblastoma Research and Treatments (8 papers) and Transgenic Plants and Applications (7 papers). JM Lambert is often cited by papers focused on Toxin Mechanisms and Immunotoxins (16 papers), Neuroblastoma Research and Treatments (8 papers) and Transgenic Plants and Applications (7 papers). JM Lambert collaborates with scholars based in United States. JM Lambert's co-authors include W A Blättler, V S Goldmacher, L Eliseo, Jerome Ritz, F Coral, N Spector, Albert R. Collinson, AS Freedman, Lee M. Nadler and KC Anderson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

JM Lambert

19 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JM Lambert United States 15 588 302 300 243 197 19 851
Maria-Ana Ghetie United States 14 376 0.6× 178 0.6× 330 1.1× 261 1.1× 216 1.1× 16 692
K A Krolick United States 13 367 0.6× 165 0.5× 275 0.9× 158 0.7× 65 0.3× 20 598
Virginia Gray Johnson United States 7 331 0.6× 145 0.5× 305 1.0× 321 1.3× 133 0.7× 8 711
Matilde Merlin Italy 10 184 0.3× 162 0.5× 72 0.2× 335 1.4× 221 1.1× 14 655
G. Seemann Germany 11 398 0.7× 35 0.1× 190 0.6× 299 1.2× 135 0.7× 18 786
Gisela Schön Germany 9 208 0.4× 120 0.4× 103 0.3× 97 0.4× 79 0.4× 12 328
Ursula Garrigues United States 9 289 0.5× 54 0.2× 238 0.8× 217 0.9× 166 0.8× 9 584
Joan A. Boden United Kingdom 18 112 0.2× 97 0.3× 511 1.7× 392 1.6× 213 1.1× 31 772
G Weil-Hillman United States 12 342 0.6× 42 0.1× 62 0.2× 103 0.4× 163 0.8× 16 452
L. Robson United Kingdom 14 130 0.2× 50 0.2× 543 1.8× 501 2.1× 212 1.1× 16 786

Countries citing papers authored by JM Lambert

Since Specialization
Citations

This map shows the geographic impact of JM Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JM Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JM Lambert more than expected).

Fields of papers citing papers by JM Lambert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JM Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JM Lambert. The network helps show where JM Lambert may publish in the future.

Co-authorship network of co-authors of JM Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of JM Lambert. A scholar is included among the top collaborators of JM Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JM Lambert. JM Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lynch, Thomas J., JM Lambert, F Coral, et al.. (1997). Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.. Journal of Clinical Oncology. 15(2). 723–734. 48 indexed citations
2.
3.
O’Connor, Rosemary, Cheng‐Che Liu, Yali Liu, et al.. (1995). Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors. Blood. 86(11). 4286–4294. 34 indexed citations
4.
Goldmacher, V S, et al.. (1994). Anti-CD38-blocked ricin: an immunotoxin for the treatment of multiple myeloma [see comments]. Blood. 84(9). 3017–3025. 62 indexed citations
5.
Goldmacher, V S, et al.. (1994). Anti-CD38-blocked ricin: an immunotoxin for the treatment of multiple myeloma [see comments]. Blood. 84(9). 3017–3025. 56 indexed citations
6.
Grossbard, Michael L., JM Lambert, V S Goldmacher, et al.. (1993). Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.. Journal of Clinical Oncology. 11(4). 726–737. 128 indexed citations
7.
Gribben, JG, AS Freedman, JM Lambert, et al.. (1993). Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non- Hodgkin's lymphoma. Blood. 81(9). 2263–2271. 3 indexed citations
8.
Gribben, JG, AS Freedman, JM Lambert, et al.. (1993). Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non- Hodgkin's lymphoma. Blood. 81(9). 2263–2271. 74 indexed citations
9.
Freedman, AS, Jerome Ritz, F Coral, et al.. (1992). Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion. Blood. 79(3). 576–585. 131 indexed citations
10.
Freedman, AS, Jerome Ritz, F Coral, et al.. (1992). Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion. Blood. 79(3). 576–585. 8 indexed citations
11.
Griffin, JD, et al.. (1991). Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells. Blood. 77(11). 2404–2412. 3 indexed citations
12.
Lambert, JM, V S Goldmacher, Albert R. Collinson, Lee M. Nadler, & W A Blättler. (1991). An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.. PubMed. 51(23 Pt 1). 6236–42. 103 indexed citations
13.
Griffin, JD, et al.. (1991). Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells. Blood. 77(11). 2404–2412. 54 indexed citations
14.
Scott, Charles F., Gordon D. McIntyre, JM Lambert, et al.. (1989). Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.. The Journal of Immunology. 142(11). 4105–4112. 30 indexed citations
15.
Goldmacher, Victor S., W A Blättler, JM Lambert, Gordon D. McIntyre, & Jean K. Stewart. (1989). Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.. Molecular Pharmacology. 36(5). 818–822. 21 indexed citations
16.
Tedder, Thomas F., V S Goldmacher, JM Lambert, & Stuart F. Schlossman. (1986). Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.. The Journal of Immunology. 137(4). 1387–1391. 36 indexed citations
17.
18.
Goldmacher, V S, Janet Anderson, W A Blättler, JM Lambert, & Peter D. Senter. (1985). Antibody-complement-mediated cytotoxicity is enhanced by ribosome-inactivating proteins.. The Journal of Immunology. 135(6). 3648–3651. 19 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria-Ana Ghetie Breakdown of academic impact, for papers by K A Krolick Breakdown of academic impact, for papers by Virginia Gray Johnson Breakdown of academic impact, for papers by Matilde Merlin Breakdown of academic impact, for papers by G. Seemann Breakdown of academic impact, for papers by Gisela Schön Breakdown of academic impact, for papers by Ursula Garrigues Breakdown of academic impact, for papers by Joan A. Boden Breakdown of academic impact, for papers by G Weil-Hillman Breakdown of academic impact, for papers by L. Robson
Rankless by CCL
2026